Cholesterol lowering drugs can prevent breast cancer, scientists have found

[China Pharmaceutical network health care] cholesterol lowering drugs may reduce the risk of breast cancer! A 14-year study in the UK has found that women who have high cholesterol levels and take cholesterol lowering drugs have a lower risk of breast cancer and therefore death, suggesting that cholesterol lowering drugs may be associated with a lower risk of breast cancer From January 1, 2000 to March 31, 2013, the researchers extracted data of more than 16000 women aged 40 or over who had found high cholesterol level and the same number of women with normal cholesterol level in the same age group By 2013, they were followed up by researchers, who obtained their breast cancer and deaths from the National Bureau of statistics The study found that women with higher cholesterol levels were 45 percent less likely to develop breast cancer than those with lower cholesterol levels, while those with higher cholesterol levels were 40 percent less likely to die, excluding factors such as age, gender, race, and other causes of death Previous studies have shown a link between cholesterol levels and breast cancer, the researchers said However, this finding shows that people with higher cholesterol levels have a lower risk of breast cancer and therefore a lower mortality rate, indicating the existence of a protective mechanism, which is likely to be related to cholesterol lowering drugs   Paul Carter, the lead author of the study, said that their previous studies and other related animal studies showed that statins can reduce the risk of breast cancer, while the new research confirmed that hospitalized women with high cholesterol levels have a lower risk of breast cancer, so it can be inferred that the use of cholesterol lowering drugs has a preventive effect on breast cancer, Thus, the mortality rate was reduced Carter said they are preparing a clinical evaluation of the protective effect of statins on breast cancer patients At present, statins can be used as prescription drugs for breast cancer patients with high cholesterol level, high-risk groups of cardiovascular disease and patients, but they can not be used to prevent and treat breast cancer If the clinical evaluation has positive results, it may change this situation Original title: cholesterol lowering drugs can reduce the risk and mortality of breast cancer